BehavioralCare/PSSNY CareLine compliance program for homebound to debut in New York in November.
Executive Summary
NEW YORK CARELINE PHARMACY COMPLIANCE INTERVENTION PROGRAM, run by the Irvine, Calif.-based firm BehavioralCare and the Pharmacists Society of the State of New York, has secured commitments from insurers and unions to participate beginning in November. The CareLine program, "a proactive telephone-based reminder, verification, support and reporting service," focuses on homebound but ambulatory patients who otherwise would be consigned to nursing home and long-term care facilities. The cost of the program is about $350 per patient per month, a fraction of the cost of institutional care, according to CareLine materials.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth